Name: UMIN ID:
Unique ID issued by UMIN | UMIN000023108 |
---|---|
Receipt number | R000024791 |
Scientific Title | A multicenter randomized phase III study for recurrent glioblastoma comparing bevacizumab alone with dose-dense temozolomide followed by bevacizumab (JCOG1308C, RE-GEND-pIII) |
Date of disclosure of the study information | 2016/07/11 |
Last modified on | 2018/02/27 18:06:31 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/07/11 12:51:42 | ||
2 | Update | 2018/02/27 18:06:31 | Institutions |